Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid

Daniel, Bella Devaleenal and Shanmugam, Sivakumar and Mehta, Rashi and Bhalla, Manpreet and Mariappan, Muthuvijayalakshmi and Ramraj, Balaji and Awasthi, Avijit Kumar and Patel, Pranav and Jain, Amita and Jain, Parul and Kumar, Chetan and Oswal, Vikas and Singla, Neeta and Kumar, Santosh and Dave, Jigna and Vadgama, Parul and Bhatnagar, Anuj K and Kant, Surya and Prabhakaran, Rathinam and Tamakuwala, Grinish and Mukherjee, Rishikesh Nath and Santhanakrishnan, Ramesh Kumar and Dhandapani, Ravikumar and Nagarajan, Naveen kumar and Kumaravadivelu, Shanmugapriya and Bharathi, Jeyadeepa and Sridhar, Anand and Ramachandran, Ranjani and Matoo, Sanjay K and Chinnaiyan, Ponnuraja and Jaju, Jyoti and Chandrasekaran, Padmapriyadarsini (2025) Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid. Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid, 106509.

Text 202515.pdf - Published Version Download (1MB)

Abstract

Assess the effectiveness of bedaquiline, pretomanid and linezolid (BPaL) regimens with varying doses and duration of linezolid at the end of 48 weeks post treatment among drug resistant tuberculosis (DR TB) patients.

Affiliation:	ICMR-National Institute for Research in Tubercuosis
Item Type:	Article
Uncontrolled Keywords:	Drug resistant tuberculosis, Linezolid, Dose reduction India Recurrence, Bedaquiline, Pretomanid, Treatment outcome
Subjects:	Tuberculosis > Clinical Research
Divisions:	Clinical Research
Depositing User:	Mrs. N Lakshmi
Date Deposited:	03 Jun 2025 06:09
Last Modified:	03 Jun 2025 06:09
URI:	http://eprints.nirt.res.in/id/eprint/2043

Actions (login required)

View Item